#WorldOrphanUSA: Emil Kakkis, MD, PhD, founder and CEO of @ultragenyx, discusses the use of #biomarkers to enable successful development of disease-modifying therapies for #RareDisease during a @OrphanConf session. #OrphanDrugUSA #RDAatWODC
0
2
5
193
0
Download Image